Literature DB >> 3881768

Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site.

L E Walker, T A Ketler, R A Houghten, G Schulz, A Chersi, R A Reisfeld.   

Abstract

A chemically synthesized peptide (sequence in text) homologous to residues 61-83 of the HLA-B7 heavy chain, induced antibodies that specifically recognized the HLA heavy chain-beta 2-microglobulin complex and the free heavy chain of the HLA-B7 antigen. These antibodies specifically immunoprecipitated the HLA-B7 beta 2-microglobulin complex solubilized from human lymphoblastoid cells by nonionic detergents and reacted with free HLA-B7 heavy chains in blots on nitrocellulose. These observations suggest that the antigenic conformation of this region of the HLA-B7 molecule is independent of the presence of beta 2-microglobulin and that amino acid residues 61-83 mimic an alloreactive site expressed by the HLA-B7 antigen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881768      PMCID: PMC397075          DOI: 10.1073/pnas.82.2.539

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants.

Authors:  J López de Castro; R Bragado; D M Strong; J L Strominger
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

4.  Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.

Authors:  J A López de Castro; J L Strominger; D M Strong; H T Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

5.  Improved quantification of cellular cytotoxicity reactions: determination of kinetic parameters for natural cytotoxicity by a distribution-free procedure.

Authors:  D M Callewaert; S P Smeekens; N H Mahle
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

6.  Prediction of chain turns in globular proteins on a hydrophobic basis.

Authors:  G D Rose
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

7.  Anti-HLA antibodies of predetermined specificity: a chemically synthesized peptide induces antibodies specific for HLA-A,B heavy chain.

Authors:  W R Church; L E Walker; R A Houghten; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.

Authors:  G Schulz; T F Bumol; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  The free and the beta 2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28.

Authors:  V Quaranta; L E Walker; G Ruberto; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-CW3).

Authors:  R Sodoyer; M Damotte; T L Delovitch; J Trucy; B R Jordan; T Strachan
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

View more
  12 in total

1.  Definition of epitopes on HLA class I molecules by polyclonal antipeptide sera.

Authors:  M Bouillot; J Choppin; J P Levy
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.

Authors:  E P Cowan; M L Jelachich; W E Biddison; J E Coligan
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  A transposable epitope of HLA-B7, B40 molecules.

Authors:  J P Ways; D A Lawlor; A M Wan; P Parham
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 4.  Functional sites of human class I MHC molecules: paradigms a dozen?

Authors:  P Parham
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

5.  Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides.

Authors:  A Chersi; M C Morganti; F Chillemi; R Houghten; C Cenciarelli
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

6.  Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles.

Authors:  D F Steiner; J Michael; R Houghten; M Mathieu; P R Gardner; M Ravazzola; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.

Authors:  G Tuchscherer; C Servis; G Corradin; U Blum; J Rivier; M Mutter
Journal:  Protein Sci       Date:  1992-10       Impact factor: 6.725

8.  Novel function for beta 1 integrins in keratinocyte cell-cell interactions.

Authors:  H Larjava; J Peltonen; S K Akiyama; S S Yamada; H R Gralnick; J Uitto; K M Yamada
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

9.  Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.

Authors:  D Koeller; R Lieberman; J Miyazaki; E Appella; K Ozato; D W Mann; J Forman
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

10.  In vivo analyses of integrin beta 1 subunit function in fibronectin matrix assembly.

Authors:  T Darribère; K Guida; H Larjava; K E Johnson; K M Yamada; J P Thiery; J C Boucaut
Journal:  J Cell Biol       Date:  1990-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.